Amarantus Bioscience Holdings Stock Analysis
| AMBS Stock | USD 0.0001 0.00 0.00% |
Amarantus Bioscience Holdings is undervalued with Real Value of 2.12E-4 and Hype Value of 9.6E-5. The main objective of Amarantus Bioscience pink sheet analysis is to determine its intrinsic value, which is an estimate of what Amarantus Bioscience Holdings is worth, separate from its market price. There are two main types of Amarantus Bioscience's stock analysis: fundamental analysis and technical analysis.
The Amarantus Bioscience pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Amarantus |
Amarantus Pink Sheet Analysis Notes
The company recorded a loss per share of 0.03. Amarantus Bioscience had not issued any dividends in recent years. The entity had 1:150 split on the 10th of June 2015. Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York. Amarantus Bioscience operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Amarantus Bioscience Holdings is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Amarantus Bioscience Holdings please contact Gerald Commissiong at 650-862-5391 or go to https://www.amarantus.com.Amarantus Bioscience Investment Alerts
| Amarantus Bioscience is way too risky over 90 days horizon | |
| Amarantus Bioscience has some characteristics of a very speculative penny stock | |
| Amarantus Bioscience appears to be risky and price may revert if volatility continues | |
| Amarantus Bioscience has high likelihood to experience some financial distress in the next 2 years | |
| Amarantus Bioscience Holdings currently holds 20.72 M in liabilities with Debt to Equity (D/E) ratio of 0.84, which is about average as compared to similar companies. Amarantus Bioscience has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Amarantus Bioscience until it has trouble settling it off, either with new capital or with free cash flow. So, Amarantus Bioscience's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amarantus Bioscience sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amarantus to invest in growth at high rates of return. When we think about Amarantus Bioscience's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (10.58 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Amarantus Bioscience Holdings currently holds about 178 in cash with (1.8 M) of positive cash flow from operations. |
Amarantus Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.13 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amarantus Bioscience's market, we take the total number of its shares issued and multiply it by Amarantus Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 28th of December, Amarantus Bioscience shows the risk adjusted performance of 0.1427, and Mean Deviation of 48.93. Amarantus Bioscience technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Amarantus Bioscience risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Amarantus Bioscience is priced correctly, providing market reflects its regular price of 1.0E-4 per share. As Amarantus Bioscience appears to be a penny stock we also recommend to validate its jensen alpha numbers.Amarantus Bioscience Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Amarantus Bioscience middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Amarantus Bioscience. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Amarantus Bioscience Outstanding Bonds
Amarantus Bioscience issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Amarantus Bioscience uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Amarantus bonds can be classified according to their maturity, which is the date when Amarantus Bioscience Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Amarantus Bioscience Predictive Daily Indicators
Amarantus Bioscience intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Amarantus Bioscience pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Amarantus Bioscience Forecast Models
Amarantus Bioscience's time-series forecasting models are one of many Amarantus Bioscience's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Amarantus Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Amarantus Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Amarantus Bioscience prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Amarantus shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Amarantus Bioscience. By using and applying Amarantus Pink Sheet analysis, traders can create a robust methodology for identifying Amarantus entry and exit points for their positions.
Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York. Amarantus Bioscience operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Amarantus Bioscience to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Additional Tools for Amarantus Pink Sheet Analysis
When running Amarantus Bioscience's price analysis, check to measure Amarantus Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amarantus Bioscience is operating at the current time. Most of Amarantus Bioscience's value examination focuses on studying past and present price action to predict the probability of Amarantus Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amarantus Bioscience's price. Additionally, you may evaluate how the addition of Amarantus Bioscience to your portfolios can decrease your overall portfolio volatility.